TraceLink Secures Fourth Merit Award for Supply Chain Innovation

The Boston-based company, which operates the world's largest Agentic Business Network, has moved beyond simple transaction digitalization. Its proprietary model utilizes OPUS Agents—no-code AI tools that function within permissioned, multi-enterprise frameworks. By defining clear decision boundaries and governance policies, life sciences firms can now automate routine operational tasks while maintaining human oversight and auditability.

Shabbir Dahod, President and CEO of TraceLink, noted that this shift represents a broader industry evolution toward governed human-agent collaboration. The company's platform, which links over 315,000 authenticated business entities, provides the necessary context for tracking inventory, production, and logistics across fragmented partner ecosystems. This infrastructure aims to enhance resilience and productivity in sectors where supply assurance and regulatory compliance are critical to patient outcomes.